Final National Occupational Research Agenda for Immune, Infectious, and Dermal Disease Prevention (IID), 11098 [2019-05561]

Download as PDF 11098 Federal Register / Vol. 84, No. 57 / Monday, March 25, 2019 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondents Form name Middle and High School Age Adolescents ..... Middle and High School Age Adolescents ..... Middle and High School Age Adolescents ..... Parents/caregivers of adolescents .................. Parents/caregivers of adolescents .................. Youth Questionnaire ...................................... Pre/Post youth questionnaire ......................... Youth interview/focus group guide ................. Parent/Caregiver questionnaire ..................... Parent/Caregiver interview/focus group guide Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2019–05556 Filed 3–22–19; 8:45 am] BILLING CODE 4163–18–P [CDC–2018–0103; Docket Number NIOSH– 322] Final National Occupational Research Agenda for Immune, Infectious, and Dermal Disease Prevention (IID) National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of availability. AGENCY: NIOSH announces the availability of the final National Occupational Research Agenda for Immune, Infectious, and Dermal Disease Prevention. DATES: The final document was published March 19, 2019 on the CDC website. ADDRESSES: The document may be obtained at the following link: https:// www.cdc.gov/nora/councils/iid/ agenda.html. FOR FURTHER INFORMATION CONTACT: Emily Novicki, M.A., M.P.H, (NORACoordinator@cdc.gov), National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Mailstop E–20, 1600 Clifton Road NE, Atlanta, GA 30329, phone (404) 498–2581 (not a toll free number). SUPPLEMENTARY INFORMATION: On November 8, 2018, NIOSH published a request for public review in the Federal Register [83 FR 55887] of the draft version of the National Occupational Research Agenda for Immune, Infectious, and Dermal Disease Jkt 247001 DEPARTMENT OF HEALTH AND HUMAN SERVICES 1 2 2 2 2 50/60 50/60 90/60 25/60 90/60 Job Titles and/or Job Duties: All laborers who worked in any area at the Y–12 Plant in Oak Ridge, Tennessee, fabricating or processing uranium during the period from January 1, 1977, through December 31, 1994. Period of Employment: January 1, 1977 through December 31, 1994. [FR Doc. 2019–05586 Filed 3–22–19; 8:45 am] BILLING CODE 4163–19–P Centers for Disease Control Decision To Evaluate a Petition To Designate a Class of Employees From the Y–12 Plant in Oak Ridge, Tennessee, To Be Included in the Special Exposure Cohort National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, Department of Health and Human Services. ACTION: Notice. AGENCY: SUMMARY: 20,000 10,000 3,000 7,500 3,000 Average burden per response (in hours) John J. Howard, Director, National Institute for Occupational Safety and Health. BILLING CODE 4163–19–P Centers for Disease Control and Prevention 16:47 Mar 22, 2019 Frank J. Hearl, Chief of Staff, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2019–05561 Filed 3–22–19; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Sep<11>2014 Prevention. All comments received were reviewed and addressed where appropriate. Number of responses per respondent NIOSH gives notice of a decision to evaluate a petition to designate a class of employees from the Y–12 Plant in Oak Ridge, Tennessee, to be included in the Special Exposure Cohort under the Energy Employees Occupational Illness Compensation Program Act of 2000. FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, National Institute for Occupational Safety and Health, 1090 Tusculum Avenue, MS C–46, Cincinnati, OH 45226–1938, Telephone 877–222–7570. Information requests can also be submitted by email to DCAS@CDC.GOV. SUPPLEMENTARY INFORMATION: Authority: 42 CFR 83.9–83.12. Pursuant to 42 CFR 83.12, the initial proposed definition for the class being evaluated, subject to revision as warranted by the evaluation, is as follows: Facility: Y–12 Plant. Location: Oak Ridge, Tennessee. SUMMARY: PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–19–18APX] Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled Dental Survey: Improving Outpatient Antibiotic Use through Implementation and Evaluation of Core Elements of Outpatient Antibiotic Stewardship to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on August 10, 2018 to obtain comments from the public and affected agencies. CDC did not receive comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including E:\FR\FM\25MRN1.SGM 25MRN1

Agencies

[Federal Register Volume 84, Number 57 (Monday, March 25, 2019)]
[Notices]
[Page 11098]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-05561]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[CDC-2018-0103; Docket Number NIOSH-322]


Final National Occupational Research Agenda for Immune, 
Infectious, and Dermal Disease Prevention (IID)

AGENCY: National Institute for Occupational Safety and Health (NIOSH) 
of the Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: NIOSH announces the availability of the final National 
Occupational Research Agenda for Immune, Infectious, and Dermal Disease 
Prevention.

DATES: The final document was published March 19, 2019 on the CDC 
website.

ADDRESSES: The document may be obtained at the following link: https://www.cdc.gov/nora/councils/iid/agenda.html.

FOR FURTHER INFORMATION CONTACT: Emily Novicki, M.A., M.P.H, 
(NORACoordinator@cdc.gov), National Institute for Occupational Safety 
and Health, Centers for Disease Control and Prevention, Mailstop E-20, 
1600 Clifton Road NE, Atlanta, GA 30329, phone (404) 498-2581 (not a 
toll free number).

SUPPLEMENTARY INFORMATION: On November 8, 2018, NIOSH published a 
request for public review in the Federal Register [83 FR 55887] of the 
draft version of the National Occupational Research Agenda for Immune, 
Infectious, and Dermal Disease Prevention. All comments received were 
reviewed and addressed where appropriate.

Frank J. Hearl,
Chief of Staff, National Institute for Occupational Safety and Health, 
Centers for Disease Control and Prevention.
[FR Doc. 2019-05561 Filed 3-22-19; 8:45 am]
 BILLING CODE 4163-19-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.